British Hepatology Pharmacy Group. Affiliate group of BASL for pharmacists and pharmacy technicians aiming to develop knowledge/understanding of liver disorders
Joined September 2018
- Tweets 831
- Following 371
- Followers 561
- Likes 1,652
231 Photos and videos
What a great educational day we had and to see all the representation we have across the UK on #hepatology #pharmacy!
We will have many more events in the future, join us if you haven’t. It’s only £20!
basl.org.uk/index.cfm/member…
2
134
BHPG retweeted
Mar 22
Naltrexone should be first line for AUD in people with cirrhosis
It is increasingly uncomfortable to see baclofen mentioned alongside it, or even acamprosate
4
35
130
12,302
Only 2 weeks left to our annual educational event in London! Have a look and sign up now to not miss your chance!
Register here: execbs.eventsair.com/bhpg-me…
17 Oct 2025
Further information on the BASL website basl.org.uk/
or register via this link execbs.eventsair.com/bhpg-me…
1
2
203
Another successful year at #BASL2025! Great to see all the inspiring 💫 work from #pharmacy.
See you all at the next BHPG meeting on 25 Nov! It’s 🆓 for BASL members!
See details 👇
📍44 Hallam Street, London
🔗 execbs.eventsair.com/bhpg-me……
ℹ️ basl.org.uk/index.cfm/even…
1
5
260
The prognosis of liver disease depends on the extent of fibrosis, which is usually staged with the use of liver biopsy. The limitations of biopsy have led to the development of noninvasive tests, which Drs. Laurent Castera, Mary E. Rinella, and Emmanuel A. Tsochatzis review. Learn more: nej.md/4hwZMgj
ALT Review Article Noninvasive Assessment of Liver Fibrosis Laurent Castera, M.D., Ph.D., Mary E. Rinella, M.D., and Emmanuel A. Tsochatzis, M.D., Ph.D. A figure showing the diagnosis, staging, and progression of liver fibrosis. The NEJM identity sits at the bottom.
4
343
1,096
77,043
BHPG retweeted
17 Oct 2025
Further information on the BASL website basl.org.uk/
or register via this link execbs.eventsair.com/bhpg-me…
6
3
814
BHPG retweeted
14 Oct 2025
Complications of Proton Pump Therapy 💊
One of the best figures I’ve seen in a long time.
On your next ward round or in the clinic think about whether your patient really needs to be on a PPI. #GITwitter #livertwitter #gutmicrobiome
#AMR
gastrojournal.org/article/s0…
4
39
115
13,623
BHPG retweeted
11 Oct 2025
🟢 10/14 | BASL × FG Special Issue
“Personalised treatment is reshaping how we manage difficult autoimmune hepatitis.”
🧬 Optimised thiopurine therapy metabolite monitoring now standard of care
💊 MMF established as leading 2nd-line — and viable 1st-line in select cases
🧪 Tacrolimus, infliximab & rituximab emerging for refractory disease
📰 Read the full review ➡️ fg.bmj.com/content/16/e1/e77
#AutoimmuneHepatitis #Hepatology #FGBASLSpecialIssue
@basl_events @heppharm @livernursing @LiverAHPs @Liver4Lifeuk @f4liverresearch @IQILS_Liver @LiverTrust @EASLedu @EASLnews @BritSocGastro @BavenoCoop @BCLC_group @ILCAnews @APASLnews @liverfellow @my_ueg @UKCPAGastro
@PhilSmithIsBack @OTavabie @dr_aditi_kumar @TrevorTabone @eathar_s @IrenePerezMD @KGananandan @zare_benjamin @medicalreg @dtleiberman @BSGtrainees @drkeithsiau @ebtapper @DrLChina @acv69cardenas @GeriKeane @jamesbmaurice @ClinicLiver
2
12
32
2,663
🔔 Useful tools and information for all pharmacists helping to write and implement clinical guidelines for #hepatology in 🇬🇧
📢 NEW! EASL’s new Guidelines Dissemination Programme advances liver care by promoting awareness and uptake of Clinical Practice Guidelines. Its key initiative, the EASL Guidelines Implementation Programme, turns recommendations into practical tools for everyday use.
Discover the first edition focused on the EASL–EASD–EASO CPGs for #MASLD: EASL MASLD Guidelines Implementation Programme: easlcampus.eu/easl-guideline…
#LiverTwitter #LiverX @DebbieShawcros1 @analleo @FrancqueSven @MajaThiele
1
200
Always lovely to hear great engagement and response from our efforts! ✨
@Yun_Pharmacist definitely outdid herself on summarising the use of GLP1RA and the future of MASLD therapy for all of us.
9 Oct 2025
GLP-1 agonists: Benefits and challenges. One of the hottest topics at the moment in light of MASLD/MASH (shown by the amount of ppl who left after the talk to go back to the medics meeting!!). Thank you @Yun_Pharmacist for a great informative talk @heppharm @livernursing @BASLedu
4
231
Posters @ #BASL2025: @ClaireBullen13 presents data on repatriating immunosuppression prescribing to referral hospitals, enabling transplant recipients access care closer to home and align with the #NHS 10 year plan ambitions.
@CUH_CambsLiver @CUH_NHS
2
3
445
Arron Jones presenting on current and emerging treatment options for #PBC, highlighting data collected from our group on elafibranor.
#BASL2025 @NHSBartsHealth @PBCFoundation @BASLedu @LiverAHPs
1
4
868
BHPG retweeted
9 Oct 2025
Great to see so many delegates at #BASL2025!
Perfect time to highlight our next event!
Intro to hep day in London - 7th Nov 25 in London
Link to registration: execbs.eventsair.com/basl-in…
1
5
8
647
Posters @ #BASL2025: @fatemajessa presents her work on a digital referral to drive efficiency in referring rifaximin patients to primary care, improving patient access in treating hepatic encephalopathy.
@RoyalFreeNHS
1
4
372
Congrats to our research pharmacist Aaron Jones from Bart’s 🥇 on an excellent abstract and presentation on fracture risk in decomp cirrhosis @ #BASL2025.
9 Oct 2025
BLNA 2025 D2 PM kicked off with the oral presentations! Home-based virtual prehabilitation @katiesramos, Fracture risk in decomp cirrhosis (Arron Jones) @heppharm, Enhancing HCC care & The impact of a CNS led holistic needs Ax on a patients HCC journey @BASLedu @livernursing
5
519
Posters @ #basl2025: Barts #pharmacist Eva Lau presents her novel pharmacist led virtual messaging service for #hepatitis b patient to improve service efficiency.
4
272